Anthrax Vaccine: A Dilemma for Homeland Security
Authors
Rempfer, Thomas L.
Subjects
Advisors
Date of Issue
2009-05-00
Date
2009-05
Publisher
Monterey, CA; Naval Postgraduate School Center for Homeland Defense and Security
Language
Abstract
Past problems with the Department of Defense anthrax vaccine currently impact Department of Homeland Security and the Department of Health and Human Services policy. Following the 2001 anthrax letter attacks, those departments included the old anthrax vaccine in the Strategic National Stockpile. This article explores the Department of Defense'۪s experience with the vaccine, enumerating past safety, efficacy, regulatory, and legal problems. Public health policy alternative courses of action are suggested, including use of antibiotics and development of a new vaccine.
Type
Article
Description
This article appeared in Homeland Security Affairs (May 2009), v.5 no.2
Series/Report No
Department
Organization
Center for Homeland Defense and Security (CHDS)
Identifiers
NPS Report Number
Sponsors
Funder
Format
Citation
Homeland Security Affairs (May 2009), v.5 no.2
Distribution Statement
Approved for public release; distribution is unlimited.
Rights
The copyright of all articles published in Homeland Security Affairs rests with the author[s] of the articles. Any commercial use of Homeland Security Affairs or the articles published herein is expressly prohibited without the written consent of the copyright holder. Anyone can copy, distribute, or reuse these articles as long as the author and original source are properly cited.